Annual FCF
$3.28 B
-$646.30 M-16.47%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual free cash flow is currently $3.28 billion, with the most recent change of -$646.30 million (-16.47%) on 31 December 2023. During the last 3 years, it has risen by +$285.20 million (+9.53%). VRTX annual FCF is now -16.47% below its all-time high of $3.93 billion, reached on 31 December 2022.VRTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$1.30 B
+$5.13 B+133.99%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly free cash flow is currently $1.30 billion, with the most recent change of +$5.13 billion (+133.99%) on 30 September 2024. Over the past year, it has increased by +$74.30 million (+6.05%). VRTX quarterly FCF is now at all-time high.VRTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$1.35 B
+$74.30 M+5.21%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated TTM free cash flow is currently -$1.35 billion, with the most recent change of +$74.30 million (+5.21%) on 30 September 2024. Over the past year, it has dropped by -$5.56 billion (-132.14%). VRTX TTM FCF is now -132.14% below its all-time high of $4.21 billion, reached on 30 September 2023.VRTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.5% | +6.0% | -132.1% |
| 3 y3 years | +9.5% | +48.9% | -170.4% |
| 5 y5 years | +179.1% | +319.4% | -199.1% |
VRTX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -16.5% | +36.1% | at high | +134.0% | -132.1% | +5.2% |
| 5 y | 5 years | -16.5% | +179.1% | at high | +134.0% | -132.1% | +5.2% |
| alltime | all time | -16.5% | +586.9% | at high | +134.0% | -132.1% | +5.2% |
Vertex Pharmaceuticals Incorporated Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.30 B(-134.0%) | -$1.35 B(-5.2%) |
| June 2024 | - | -$3.83 B(-462.0%) | -$1.43 B(-141.0%) |
| Mar 2024 | - | $1.06 B(+793.0%) | $3.48 B(+6.1%) |
| Dec 2023 | $3.28 B(-16.5%) | $118.50 M(-90.3%) | $3.28 B(-22.0%) |
| Sept 2023 | - | $1.23 B(+14.2%) | $4.21 B(+8.4%) |
| June 2023 | - | $1.07 B(+25.3%) | $3.88 B(-0.3%) |
| Mar 2023 | - | $857.80 M(-17.9%) | $3.89 B(-0.9%) |
| Dec 2022 | $3.93 B(+63.0%) | $1.04 B(+15.9%) | $3.93 B(+2.9%) |
| Sept 2022 | - | $901.30 M(-17.0%) | $3.81 B(+0.7%) |
| June 2022 | - | $1.09 B(+21.7%) | $3.79 B(+54.5%) |
| Mar 2022 | - | $892.60 M(-4.4%) | $2.45 B(+1.8%) |
| Dec 2021 | $2.41 B(-19.5%) | $933.20 M(+6.7%) | $2.41 B(+25.5%) |
| Sept 2021 | - | $874.80 M(-450.5%) | $1.92 B(+8.0%) |
| June 2021 | - | -$249.60 M(-129.4%) | $1.78 B(-41.7%) |
| Mar 2021 | - | $850.10 M(+91.5%) | $3.05 B(+1.8%) |
| Dec 2020 | $2.99 B(+100.4%) | $443.84 M(-39.4%) | $2.99 B(+0.5%) |
| Sept 2020 | - | $732.95 M(-28.2%) | $2.98 B(+16.5%) |
| June 2020 | - | $1.02 B(+28.2%) | $2.56 B(+28.9%) |
| Mar 2020 | - | $796.25 M(+85.5%) | $1.98 B(+32.8%) |
| Dec 2019 | $1.49 B(+27.2%) | $429.27 M(+38.3%) | $1.49 B(+9.6%) |
| Sept 2019 | - | $310.50 M(-30.6%) | $1.36 B(-3.5%) |
| June 2019 | - | $447.39 M(+45.9%) | $1.41 B(+12.3%) |
| Mar 2019 | - | $306.74 M(+2.6%) | $1.26 B(+7.1%) |
| Dec 2018 | $1.17 B(+100.6%) | $298.93 M(-17.1%) | $1.17 B(+10.8%) |
| Sept 2018 | - | $360.44 M(+23.4%) | $1.06 B(+55.5%) |
| June 2018 | - | $292.09 M(+30.8%) | $682.12 M(+23.1%) |
| Mar 2018 | - | $223.38 M(+21.1%) | $554.31 M(-5.3%) |
| Dec 2017 | $585.52 M(+226.1%) | $184.53 M(-1132.4%) | $585.52 M(+10.3%) |
| Sept 2017 | - | -$17.87 M(-110.9%) | $530.93 M(-11.6%) |
| June 2017 | - | $164.28 M(-35.5%) | $600.58 M(+30.2%) |
| Mar 2017 | - | $254.59 M(+95.9%) | $461.24 M(+156.9%) |
| Dec 2016 | $179.54 M(-143.7%) | $129.94 M(+151.0%) | $179.54 M(+171.1%) |
| Sept 2016 | - | $51.77 M(+107.6%) | $66.22 M(-217.4%) |
| June 2016 | - | $24.94 M(-192.0%) | -$56.42 M(-72.5%) |
| Mar 2016 | - | -$27.11 M(-263.2%) | -$205.05 M(-50.1%) |
| Dec 2015 | -$410.73 M(-34.2%) | $16.62 M(-123.4%) | -$410.73 M(-34.2%) |
| Sept 2015 | - | -$70.87 M(-42.7%) | -$623.81 M(-4.0%) |
| June 2015 | - | -$123.69 M(-46.9%) | -$649.88 M(-2.4%) |
| Mar 2015 | - | -$232.79 M(+18.5%) | -$665.82 M(+6.6%) |
| Dec 2014 | -$624.31 M(+457.1%) | -$196.46 M(+102.6%) | -$624.31 M(+47.7%) |
| Sept 2014 | - | -$96.94 M(-30.6%) | -$422.57 M(+18.1%) |
| June 2014 | - | -$139.62 M(-27.0%) | -$357.86 M(+62.0%) |
| Mar 2014 | - | -$191.29 M(-3717.4%) | -$220.96 M(+97.2%) |
| Dec 2013 | -$112.06 M(-157.0%) | $5.29 M(-116.4%) | -$112.06 M(+6.9%) |
| Sept 2013 | - | -$32.23 M(+1081.6%) | -$104.83 M(-976.2%) |
| June 2013 | - | -$2.73 M(-96.7%) | $11.96 M(-89.8%) |
| Mar 2013 | - | -$82.39 M(-758.4%) | $117.56 M(-40.2%) |
| Dec 2012 | $196.70 M(+80.2%) | $12.51 M(-85.2%) | $196.70 M(-73.4%) |
| Sept 2012 | - | $84.56 M(-17.8%) | $738.52 M(+7.5%) |
| June 2012 | - | $102.86 M(-3275.7%) | $686.87 M(+131.0%) |
| Mar 2012 | - | -$3.24 M(-100.6%) | $297.38 M(+172.5%) |
| Dec 2011 | $109.14 M(-116.2%) | $554.33 M(+1584.4%) | $109.14 M(-117.4%) |
| Sept 2011 | - | $32.91 M(-111.5%) | -$625.73 M(-24.9%) |
| June 2011 | - | -$286.63 M(+49.7%) | -$833.46 M(+25.3%) |
| Mar 2011 | - | -$191.48 M(+6.1%) | -$665.40 M(-1.2%) |
| Dec 2010 | -$673.50 M(+49.3%) | -$180.53 M(+3.3%) | -$673.50 M(+11.7%) |
| Sept 2010 | - | -$174.82 M(+47.4%) | -$602.87 M(+32.7%) |
| June 2010 | - | -$118.57 M(-40.6%) | -$454.44 M(-0.9%) |
| Mar 2010 | - | -$199.57 M(+81.6%) | -$458.52 M(+1.6%) |
| Dec 2009 | -$451.08 M(+74.4%) | -$109.91 M(+316.5%) | -$451.08 M(+1.4%) |
| Sept 2009 | - | -$26.39 M(-78.5%) | -$445.01 M(-20.0%) |
| June 2009 | - | -$122.65 M(-36.2%) | -$556.61 M(+63.8%) |
| Mar 2009 | - | -$192.14 M(+85.0%) | -$339.77 M(+31.4%) |
| Dec 2008 | -$258.66 M | -$103.84 M(-24.7%) | -$258.66 M(+21.6%) |
| Sept 2008 | - | -$137.99 M(-246.5%) | -$212.72 M(+45.4%) |
| June 2008 | - | $94.19 M(-184.8%) | -$146.30 M(-54.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$111.03 M(+91.8%) | -$321.98 M(+13.0%) |
| Dec 2007 | -$284.89 M(+419.0%) | -$57.89 M(-19.1%) | -$284.89 M(+19.5%) |
| Sept 2007 | - | -$71.57 M(-12.2%) | -$238.47 M(+229.4%) |
| June 2007 | - | -$81.49 M(+10.2%) | -$72.40 M(+19.3%) |
| Mar 2007 | - | -$73.94 M(+544.4%) | -$60.67 M(+10.5%) |
| Dec 2006 | -$54.89 M(-71.0%) | -$11.47 M(-112.1%) | -$54.89 M(-1.2%) |
| Sept 2006 | - | $94.50 M(-235.5%) | -$55.56 M(-73.6%) |
| June 2006 | - | -$69.76 M(+2.3%) | -$210.81 M(+5.9%) |
| Mar 2006 | - | -$68.16 M(+461.2%) | -$199.10 M(+5.3%) |
| Dec 2005 | -$189.01 M(+22.2%) | -$12.14 M(-80.0%) | -$189.01 M(-7.5%) |
| Sept 2005 | - | -$60.74 M(+4.6%) | -$204.31 M(+8.1%) |
| June 2005 | - | -$58.05 M(-0.0%) | -$189.07 M(+19.7%) |
| Mar 2005 | - | -$58.07 M(+111.6%) | -$157.98 M(+2.1%) |
| Dec 2004 | -$154.66 M(-16.4%) | -$27.45 M(-39.7%) | -$154.66 M(-3.4%) |
| Sept 2004 | - | -$45.51 M(+68.8%) | -$160.03 M(-0.9%) |
| June 2004 | - | -$26.95 M(-50.8%) | -$161.41 M(-11.7%) |
| Mar 2004 | - | -$54.75 M(+66.8%) | -$182.71 M(-1.2%) |
| Dec 2003 | -$184.97 M(+56.2%) | -$32.82 M(-30.0%) | -$184.97 M(+6.4%) |
| Sept 2003 | - | -$46.88 M(-2.9%) | -$173.85 M(+10.3%) |
| June 2003 | - | -$48.26 M(-15.3%) | -$157.65 M(+16.5%) |
| Mar 2003 | - | -$57.01 M(+162.8%) | -$135.33 M(+14.3%) |
| Dec 2002 | -$118.41 M(+94.3%) | -$21.69 M(-29.3%) | -$118.41 M(+78.9%) |
| Sept 2002 | - | -$30.68 M(+18.3%) | -$66.19 M(-30.7%) |
| June 2002 | - | -$25.94 M(-35.3%) | -$95.51 M(+15.8%) |
| Mar 2002 | - | -$40.09 M(-231.3%) | -$82.47 M(+35.3%) |
| Dec 2001 | -$60.95 M(+98.3%) | $30.53 M(-150.9%) | -$60.95 M(-46.2%) |
| Sept 2001 | - | -$60.00 M(+365.0%) | -$113.29 M(+73.7%) |
| June 2001 | - | -$12.90 M(-30.5%) | -$65.21 M(+109.6%) |
| Mar 2001 | - | -$18.57 M(-14.9%) | -$31.11 M(+1.2%) |
| Dec 2000 | -$30.74 M(-36.0%) | -$21.82 M(+83.1%) | -$30.74 M(+1168.7%) |
| Sept 2000 | - | -$11.92 M(-156.2%) | -$2.42 M(-75.1%) |
| June 2000 | - | $21.20 M(-216.5%) | -$9.74 M(-80.0%) |
| Mar 2000 | - | -$18.20 M(-380.0%) | -$48.80 M(+1.7%) |
| Dec 1999 | -$48.00 M(+23.1%) | $6.50 M(-133.8%) | -$48.00 M(-28.9%) |
| Sept 1999 | - | -$19.23 M(+7.7%) | -$67.50 M(+39.3%) |
| June 1999 | - | -$17.87 M(+2.7%) | -$48.47 M(+15.4%) |
| Mar 1999 | - | -$17.40 M(+33.8%) | -$42.00 M(+7.7%) |
| Dec 1998 | -$39.00 M(+153.2%) | -$13.00 M(+6400.0%) | -$39.00 M(+24.2%) |
| Sept 1998 | - | -$200.00 K(-98.2%) | -$31.40 M(-10.5%) |
| June 1998 | - | -$11.40 M(-20.8%) | -$35.10 M(+41.5%) |
| Mar 1998 | - | -$14.40 M(+166.7%) | -$24.80 M(+61.0%) |
| Dec 1997 | -$15.40 M(-65.2%) | -$5.40 M(+38.5%) | -$15.40 M(+1.3%) |
| Sept 1997 | - | -$3.90 M(+254.5%) | -$15.20 M(-19.1%) |
| June 1997 | - | -$1.10 M(-78.0%) | -$18.80 M(-53.5%) |
| Mar 1997 | - | -$5.00 M(-3.8%) | -$40.40 M(-8.8%) |
| Dec 1996 | -$44.30 M(+107.0%) | -$5.20 M(-30.7%) | -$44.30 M(+4.2%) |
| Sept 1996 | - | -$7.50 M(-67.0%) | -$42.50 M(+6.0%) |
| June 1996 | - | -$22.70 M(+155.1%) | -$40.10 M(+61.7%) |
| Mar 1996 | - | -$8.90 M(+161.8%) | -$24.80 M(+15.9%) |
| Dec 1995 | -$21.40 M(+28.9%) | -$3.40 M(-33.3%) | -$21.40 M(-10.1%) |
| Sept 1995 | - | -$5.10 M(-31.1%) | -$23.80 M(+10.2%) |
| June 1995 | - | -$7.40 M(+34.5%) | -$21.60 M(+24.9%) |
| Mar 1995 | - | -$5.50 M(-5.2%) | -$17.30 M(+4.2%) |
| Dec 1994 | -$16.60 M(-344.1%) | -$5.80 M(+100.0%) | -$16.60 M(+1975.0%) |
| Sept 1994 | - | -$2.90 M(-6.5%) | -$800.00 K(-144.4%) |
| June 1994 | - | -$3.10 M(-35.4%) | $1.80 M(-64.7%) |
| Mar 1994 | - | -$4.80 M(-148.0%) | $5.10 M(-25.0%) |
| Dec 1993 | $6.80 M(-200.0%) | $10.00 M(-3433.3%) | $6.80 M(-215.3%) |
| Sept 1993 | - | -$300.00 K(-250.0%) | -$5.90 M(-10.6%) |
| June 1993 | - | $200.00 K(-106.5%) | -$6.60 M(-13.2%) |
| Mar 1993 | - | -$3.10 M(+14.8%) | -$7.60 M(+11.8%) |
| Dec 1992 | -$6.80 M(+83.8%) | -$2.70 M(+170.0%) | -$6.80 M(+65.9%) |
| Sept 1992 | - | -$1.00 M(+25.0%) | -$4.10 M(+32.3%) |
| June 1992 | - | -$800.00 K(-65.2%) | -$3.10 M(+34.8%) |
| Mar 1992 | - | -$2.30 M | -$2.30 M |
| Dec 1991 | -$3.70 M | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual free cash flow?
- What is the all time high annual FCF for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual FCF year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly free cash flow?
- What is the all time high quarterly FCF for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly FCF year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM free cash flow?
- What is the all time high TTM FCF for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM FCF year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual free cash flow?
The current annual FCF of VRTX is $3.28 B
What is the all time high annual FCF for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual free cash flow is $3.93 B
What is Vertex Pharmaceuticals Incorporated annual FCF year-on-year change?
Over the past year, VRTX annual free cash flow has changed by -$646.30 M (-16.47%)
What is Vertex Pharmaceuticals Incorporated quarterly free cash flow?
The current quarterly FCF of VRTX is $1.30 B
What is the all time high quarterly FCF for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly free cash flow is $1.30 B
What is Vertex Pharmaceuticals Incorporated quarterly FCF year-on-year change?
Over the past year, VRTX quarterly free cash flow has changed by +$74.30 M (+6.05%)
What is Vertex Pharmaceuticals Incorporated TTM free cash flow?
The current TTM FCF of VRTX is -$1.35 B
What is the all time high TTM FCF for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM free cash flow is $4.21 B
What is Vertex Pharmaceuticals Incorporated TTM FCF year-on-year change?
Over the past year, VRTX TTM free cash flow has changed by -$5.56 B (-132.14%)